<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The role of intrauterine <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and future risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in human offspring is debated </plain></SENT>
<SENT sid="1" pm="."><plain>We studied <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance in adult offspring of women with either <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> mellitus (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>) or type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, taking the impact of both intrauterine <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and genetic predisposition to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> into account </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: The <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance status following a 2-h 75-g oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (OGTT) was evaluated in 597 subjects, primarily Caucasians, aged 18-27 years </plain></SENT>
<SENT sid="3" pm="."><plain>They were subdivided into four groups according to maternal <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism during pregnancy and genetic predisposition to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>: 1) offspring of women with diet-treated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> (O-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>), 2) offspring of genetically predisposed women with a <z:mpath ids='MPATH_458'>normal</z:mpath> OGTT (O-NoGDM), 3) offspring of women with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (O-type 1), and 4) offspring of women from the background population (O-BP) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The prevalence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and pre-<z:mp ids='MP_0002055'>diabetes</z:mp> (<z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> or impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>) in the four groups was 21, 12, 11, and 4%, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>In multiple logistic regression analysis, the adjusted odds ratios (ORs) for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>/pre-<z:mp ids='MP_0002055'>diabetes</z:mp> were 7.76 (95% CI 2.58-23.39) in O-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> and 4.02 (1.31-12.33) in O-type 1 compared with O-BP </plain></SENT>
<SENT sid="6" pm="."><plain>In O-type 1, the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>/pre-<z:mp ids='MP_0002055'>diabetes</z:mp> was significantly associated with elevated maternal blood <z:chebi fb="105" ids="17234">glucose</z:chebi> in <z:e sem="disease" ids="C0878751" disease_type="Disease or Syndrome" abbrv="">late pregnancy</z:e>: OR 1.41 (1.04-1.91) per mmol/l </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: A hyperglycemic intrauterine environment appears to be involved in the pathogenesis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>/pre-<z:mp ids='MP_0002055'>diabetes</z:mp> in adult offspring of primarily Caucasian women with either diet-treated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> or type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> during pregnancy </plain></SENT>
</text></document>